Biogen Inc. buy Royal Bank of Canada
Start price
02.08.24
/
50%
€188.45
Target price
02.08.25
€267.50
Performance (%)
-39.72%
End price
03.08.25
€113.60
Summary
This prediction ended on 03.08.25 with a price of €113.60. The BUY prediction by Royal_Bank_of_Canada for Biogen Inc. performed very badly with a performance of -39.72%. Royal_Bank_of_Canada has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 15.241% | 15.241% | -18.976% |
| iShares Core DAX® | 2.709% | 3.467% | 27.799% |
| iShares Nasdaq 100 | 0.867% | 5.198% | 18.207% |
| iShares Nikkei 225® | 3.135% | 9.423% | 11.810% |
| iShares S&P 500 | 0.886% | 3.586% | 12.096% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank of Canada from $282.00 to $292.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten